Stock listing
Sk Biopharmaceuticals Co., Ltd.
Selected listing: 326030 · KRX · KRW · KR
Sk Biopharmaceuticals Co., Ltd. (KRX:326030), Health Technology. Latest release Apr 6, 2026: SK Life Science, Inc. to Present New Data and Epilepsy Insights…
- Ticker
- KRX:326030
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Sk Biopharmaceuticals Co., Ltd.
Sk Biopharmaceuticals Co., Ltd. is a publicly traded company on the Korean stock market under the ticker 326030. Sk Biopharmaceuticals focuses on developing innovative biopharmaceutical products to address various medical needs.
Latest news from Sk Biopharmaceuticals Co., Ltd.
SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting
April 6, 2026
SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation
November 25, 2025
SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting
November 21, 2025
New SK Life Science, Inc. Survey Reveals Communication Gaps Between Patients and Providers That Can Impact Epilepsy Care Outcomes
October 28, 2025
SK Life Science, Inc. to Host "Illuminating the Path to Added Seizure Reduction" Symposium at the 2025 American Epilepsy Society Annual Meeting
October 24, 2025
Research Sk Biopharmaceuticals Co., Ltd.
Sk Biopharmaceuticals Co., Ltd. company profile
View the public company page for Sk Biopharmaceuticals Co., Ltd. on 6ix.
Sk Biopharmaceuticals Co., Ltd. news
Read company news and market updates connected to Sk Biopharmaceuticals Co., Ltd..
Sk Biopharmaceuticals Co., Ltd. investor events
Find investor webinars, events, and replay context for Sk Biopharmaceuticals Co., Ltd..